Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide-salmeterol Axahaler versus Serevent + Pulmicort in children with asthma
2017-003330-91Phase 2Completed
- Sponsor
- SMB Laboratoires
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of budesonide and salmeterol in asthma (4 arms), sponsored by SMB Laboratoires. Primary endpoint: Baseline-adjusted area under the curve for FEV1 over 12 hours post dose. Started Oct 2017; status: completed.
02
Drugs
budesonidesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2017-003330-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003330-91.